The LSUHSC Cancer Center is seeking five faculty members who are committed to excellence in research that addresses biology and treatment of cancers that disproportionately burden the residents of Louisiana. Rank and track to be determined by qualifications.

Louisiana is at the heart of the U.S. cancer burden with high incidence and mortality from most cancers, and faces significant challenges related to cancer care and health equity and disparities. However, for qualified, motivated, and innovative applicants, these challenges afford exceptional basic science and clinical translational opportunities directed toward NIH-designated priority areas.

The LSUHSC Cancer Center is an emerging Cancer Center actively seeking NCI designation in cooperation with our partners in the Louisiana Cancer Research Center (LCRC). Leveraging significant support from the State of Louisiana, Louisiana State University (LSU), our hospital partner, LCMC Health, the LCRC, and private donors, we have a dynamic strategic plan that will achieve this goal.

The Cancer Center has existing strengths in cancers of genitourinary, gastrointestinal, and hepatobiliary systems, and female reproductive tract, cancer biology, viral oncology, inflammation, immunology, obesity, and cancer metabolism. It combines clinical expertise, an exceptional clinical trials network, and a growing cadre of basic scientists to define underlying molecular mechanisms in cancer and derive novel interventions that improve prevention, early diagnosis, and treatment of cancer for our diverse populations.

We are seeking faculty candidates with demonstrated expertise in (but not limited to) technological innovation, cancer-relevant molecular and cellular biology, genomics, epigenetics, infectious etiologies, tumor immunology, obesity, and cancer therapy development. Investigators with expertise in bioinformatics and biostatistics are strongly encouraged to apply.

An exceptional track record of accomplishments and sustained funding are preferred. Selected scientists will be offered competitive start-up funds commensurate with expertise and productivity. Team recruitment will be considered for well-established investigators. Closely mentored research/career development programs are provided for ‘early-stage’ investigators and visa sponsorship can be available, if needed.

Selected applicants will play a foundational role in defining the cancer research strategies, priorities and implementation approaches within the State and the region directed toward NCI designation.